Literature DB >> 17172930

Expression of monocyte and lymphocyte adhesion molecules is increased in isolated coronary artery ectasia.

Nesligul Yildirim1, Ishak O Tekin, Sait M Dogan, Mustafa Aydin, Metin Gursurer, Fatih Cam, Alper Gungorduk, Ayla Akoz.   

Abstract

BACKGROUND: Coronary artery ectasia is defined as localized or diffuse dilation of the coronary arteries exceeding the 1.5-fold of normal adjacent segment. Scarce data are available about the role of inflammation in coronary artery ectasia. In the present study, we aimed to evaluate the expression of CD11b and CD45 adhesion molecules in peripheral blood granulocytes, monocytes and lymphocytes from the patients with coronary artery ectasia as possible indicators of inflammation.
METHOD: The study consisted of 14 patients who had angiographically normal coronary arteries with coronary artery ectasia and 13 age and sex-matched controls without coronary artery ectasia. Cell surface adhesion molecules were detected by direct immunofluorescence evaluated by flow cytometry using monoclonal antibodies tagged with fluorescent markers. Venous blood samples were taken after coronary angiography.
RESULTS: Mean fluorescence intensity of CD45 (33.8+/-3.1 vs. 13.0+/-0.7, P<0.001) and CD11b (39.1+/-13.5 vs. 19.5+/-1.32, P<0.001) on the monocyte surface of patients with coronary artery ectasia were higher than those of controls. Similarly in patients with coronary artery ectasia, the expression of CD11b (7.5+/-0.61 vs. 5.6+/-0.2, P=0.009) and CD45 (47.5+/-3.6 vs. 36.2+/-2.5, P=0.02) on lymphocytes was also significantly higher than those of controls.
CONCLUSION: Increased levels of cellular adhesion molecules in patients with coronary artery ectasia may be an indicator of endothelial activation and inflammation and are likely to be in the causal pathway leading to coronary artery ectasia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172930     DOI: 10.1097/MCA.0b013e32801104d4

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  8 in total

1.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

2.  Further increase in the expression of activation markers on monocyte-derived dendritic cells in coronary artery disease patients with ectasia compared to patients with coronary artery disease alone.

Authors:  Nesligul Yildirim; Ishak Ozel Tekin; Mehmet Arasli; Mustafa Aydin
Journal:  Mediators Inflamm       Date:  2010-06-14       Impact factor: 4.711

3.  The Relationship Between Blood Monocyte Count and Coronary Artery Ectasia.

Authors:  Mehmet Demir; Canan Demir; Serdar Keceoglu
Journal:  Cardiol Res       Date:  2014-10-06

4.  Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia.

Authors:  Zhuoxuan Yang; Jiansong Yuan; JinGang Cui; Hao Guan; Shubin Qiao
Journal:  BMC Cardiovasc Disord       Date:  2021-03-30       Impact factor: 2.298

5.  Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia.

Authors:  Aydın Rodi Tosu; Halil İbrahim Biter
Journal:  Arch Med Sci Atheroscler Dis       Date:  2021-09-20

6.  Increased serum resistin levels associated with isolated coronary artery ectasia.

Authors:  Fatih Sivri; Ufuk Eryılmaz
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-08-31

7.  The levels of tumor necrosis factor-alpha and interleukin-6 in patients with isolated coronary artery ectasia.

Authors:  Mustafa Aydin; Ishak Ozel Tekin; Sait Mesut Dogan; Nesligul Yildirim; Mehmet Arasli; Muhammet Rasit Sayin; Ziyaettin Aktop
Journal:  Mediators Inflamm       Date:  2009-06-17       Impact factor: 4.711

8.  Inflammation in Coronary Artery Ectasia Compared to Atherosclerosis.

Authors:  Ertan Yetkin; Selcuk Ozturk; Gulay Imadoglu Yetkin
Journal:  Int J Mol Sci       Date:  2018-09-29       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.